|
|
Oriģinālais nosaukums |
|
|
Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām
|
Abbocurium |
Polija |
Acurmil |
Itālija |
Ancour |
Irāna |
Anecur |
Irāna |
Atacur |
Saūda Arābija |
Atacurin |
Irāna |
Atrabesylate |
Ēģipte |
Atracur |
Ekvadora |
Atracurio |
Argentīna, Brazīlija, Spānija |
Atracurio besilato |
Čīle, Itālija, Peru, Venecuēla |
Atracurium |
Apvienotie Arābu Emirāti, Argentīna, Austrija, Ēģipte, Irāna, Itālija, Lielbritānija, Malaizija, Saūda Arābija, Vācija, Zviedrija |
Atracurium besilat |
Austrija |
Atracurium besilate |
Amerikas Savienotās Valstis, Apvienotie Arābu Emirāti, Austrālija, Ēģipte, Irāna, Jaunzēlande, Kanāda, Saūda Arābija |
Atralex |
Malaizija |
Atrasyl |
Turcija |
Besilato Atracurio |
Čīle, Portugāle, Spānija |
Besitrac |
Brazīlija |
Faulcurium |
Ēģipte, Portugāle |
Gelolagar |
Argentīna |
Laurak |
Spānija |
Neucurium |
Turcija |
Notrixum |
Turcija |
Relactrac |
Kolumbija |
Relatrac |
Meksika |
Tracrium |
Amerikas Savienotās Valstis, Apvienotie Arābu Emirāti, Argentīna, Austrālija, Austrija, Beļģija, Čīle, Ēģipte, Ekvadora, Francija, Grieķija, Holande, Irāna, Itālija, Jaunzēlande, Kolumbija, Lielbritānija, Luksemburga, Malaizija, Maroka, Meksika, Polija, Portugāle, Rumānija, Saūda Arābija, Spānija, Šveice, Tunisija, Ungārija, Vācija, Zviedrija |
Tracumek |
Peru |
Tracurix |
Argentīna |
Tracuron |
Argentīna |
|
|
|
|
Literatūras saraksts : Atracurium besylate |
|
|
tips |
publicēšana |
285 |
Žurnāls |
Elmore RL, Contois ME, Kelly J, Noe A, Poirier A. Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs. Clin Ther 1996 ; 18: 246-255. |
300 |
Žurnāls |
Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292. |
319 |
Žurnāls |
Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999. |
402 |
Žurnāls |
Savitsky ME. Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection. Am J Hosp Pharm 1990 ; 47: 820-821. |
657 |
Žurnāls |
Pramar YV, Loucas VA, Word D. Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes. J Clin Pharm Ther 1996 ; 21: 173-175. |
660 |
Žurnāls |
Michaels MR, Stauffer GL, Haas DP. Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility. Ann Pharmacotherapy 1996 ; 30: 228-232. |
813 |
Žurnāls |
Akkermann SR, Zhang H, Mullins RE, Yaughn K. Stability of milrinone lactate in the presence of 29 critical care drugs and 4 IV solutions. Am J Health-Syst Pharm 1999 ; 56: 63-68. |
865 |
Žurnāls |
Bhatt-Mehta V, Hirata S. Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion. Int J Pharm Compound 1998 ; 2: 79-81. |
939 |
Žurnāls |
Gilbar PJ, Groves CF. Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection. Aust J Hosp Pharm 1994 ; 24: 167-170. |
1093 |
Žurnāls |
Fisher DM, Canfell, Miller RD. Stability of atracurium administered by infusion. Anesthesiology 1984 ; 61: 347-348. |
1611 |
Žurnāls |
Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506. |
1647 |
Žurnāls |
Ackland G. Physical incompatibility between atracurium and intravenous diclofenac. Anaesthesia 2001 ; 56: 294. |
1721 |
Žurnāls |
Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72. |
1803 |
Žurnāls |
Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85. |
3373 |
Žurnāls |
Khan S, Stannard N, Greijn J. Precipitation of thiopental with muscle relaxants: a potential hazard. J R Soc Med Sh Rep 2011 ; 2: 58. |
3502 |
Laboratorija |
Propofol (Diprivan®) - Summary of Products Characteristics Astra Zeneca 2012 |
3629 |
Laboratorija |
Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics Actavis UK 2014 |
3659 |
Laboratorija |
Propofol (Diprivan®) - Résumé des caractéristiques du produit AstraZeneca 2016 |
3676 |
Laboratorija |
Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit Hospira 2014 |
4428 |
Žurnāls |
Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132. |
|
|